SCHEMBL6673764

SCHEMBL6673764

CC(c1ccc(O)cc1)[C@@](C)(C(N)=O)N(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 8/20 0.39
▸ ESR2 Q92731 7/20 0.39
▸ PDCD1 Q15116 1/20 0.39
▸ CD274 Q9NZQ7 1/20 0.39
▸ ALOX5 P09917 2/20 0.33
▸ BLM P54132 1/20 0.33
▸ DEGS1 O15121 1/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ LMNA P02545 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ PGR P06401 1/20 0.32
▸ CHRM2 P08172 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ADORA3 P0DMS8 1/20 0.32
▸ AR P10275 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6672417 0.85 ESR1 (0.41) ESR1ESR2PDCD1CD274BLM
SCHEMBL7277613 0.77 MEN1 (0.40) ESR1ESR2CYP2C9NPY5R
SCHEMBL27493803 0.71 ESR1 (0.41) ESR1ESR2PDCD1CD274BLM
SCHEMBL25597560 0.70 BLM (0.47) ESR1ESR2PDCD1CD274BLM
SCHEMBL22074723 0.70 BLM (0.47) ESR1ESR2PDCD1CD274BLM
SCHEMBL22074727 0.70 BLM (0.47) ESR1ESR2PDCD1CD274BLM
SCHEMBL6673967 0.70 KDM4E (0.41) ALOX5CYP1A2CYP2D6
SCHEMBL25596210 0.70 ESR1 (0.52) ESR1ESR2PDCD1CD274LMNA
SCHEMBL9561475 0.70 ESR1 (0.52) ESR1ESR2PDCD1CD274LMNA
SCHEMBL14411802 0.69 ESR1 (0.56) ESR1ESR2PDCD1CD274BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026293-A2 HEMIASTERLIN DERIVATIVES FOR TREATING RESISTANT TUMORS WYETH HOLDINGS CORPORATION (US) 2004-04-01 — — WO claimed
WO-2004026293-A2 HEMIASTERLIN DERIVATIVES FOR TREATING RESISTANT TUMORS WYETH HOLDINGS CORPORATION (US) 2004-04-01 — — WO disclosed
Send feedback